Big dynorphin as a putative endogenous ligand for the κ-opioid receptor

Journal of Neurochemistry

Volumn 97, Issue 1, 2006, Pages 292-301

  Merg, Florence ^a   Filliol, Dominique ^a   Usynin, Ivan ^b   Bazov, Igor ^b   Bark, Niklas ^b   Hurd, Yasmin L ^b   Yakovleva, Tatjana ^b   Kieffer, Brigitte L ^a   Bakalkin, Georgy ^b,c  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

opioid receptors; Big dynorphin; Endogenous kappa ligand

Indexed keywords

COMPLEMENTARY DNA; DYNORPHIN A; DYNORPHIN B; GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; OPIATE RECEPTOR; OPIOID RECEPTOR LIKE RECEPTOR 1; PRODYNORPHIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; CONTROLLED STUDY; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LIGAND BINDING; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; RECEPTOR SENSITIVITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; BINDING, COMPETITIVE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DYNORPHINS; ENDORPHINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LIGANDS; MICE; MICE, KNOCKOUT; NEURAL PATHWAYS; NEURONS; PAIN; RADIOIMMUNOASSAY; RADIOLIGAND ASSAY; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

ANIMALIA;

EID: 33644962688     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03732.x     Document Type: Article

References (73)

1. Becker JA. Wallace A. Garzon A. Ingallinella P. Bianchi E. Cortese R. Simonin F. Kieffer BL. Pessi A. 1999 Ligands for κ-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library JBiolChem 274 27 513 27 522
2. Befort K. Filliol D. Decaillot FM. Gaveriaux-Ruff C. Hoehe MR. Kieffer BL. 2001 A single nucleotide polymorphic mutation in the human μ-opioid receptor severely impairs receptor signaling JBiolChem 276 3130 3137
3. Bennett MA. Murray TF. Aldrich JV. 2002 Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a κopioid receptor antagonist JMedChem 45 5617 5619
4. 35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity JBiolChem 273 16 865 16 873
5. Burgen AS. 1981 Conformational changes and drug action FedProc 40 2723 2728
6. Cappendijk SL. Hurd YL. Nylander I. van Ree JM. Terenius L. 1999 A heroin, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides EurJPharmacol 365 175 182
7. Chavkin C. James IF. Goldstein A. 1982 Dynorphin is a specific endogenous ligand of the κopioid receptor Science 215 413 415
8. Cheng HY. Pitcher GM. Laviolette SR. et al. 2002 DREAM is a critical transcriptional repressor for pain modulation Cell 108 31 43
9. Christensson-Nylander I. Nyberg F. Ragnarsson U. Terenius L. 1985 A general procedure for analysis of pro-enkephalin B derived opioid peptides RegulPeptides 11 65 76
10. Christensson-Nylander I. Herrera-Marschitz M. Staines W. Hokfelt T. Terenius L. Ungerstedt U. Cuello C. Oertel WH. Goldstein M. 1986 Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies ExpBrain Res 64 169 192
11. Costigan M. Woolf CJ. 2002 No DREAM, no pain. Closing the spinal gate Cell 108 297 300
12. Day R. Akil H. 1989 The post-translational processing of prodynorphin in the rat anterior pituitary Endocrinology 124 2392 2405
13. Decaillot FM. Befort K. Filliol D. Yue S. Walker P. Kieffer BL. 2003 Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation NatStructBiol 10 629 636
14. Erne D. Sargent DF. Schwyzer R. 1985 Preferred conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes Biochemistry 24 4261 4263
15. Fallon JH. Leslie FM. 1986 Distribution of dynorphin and enkephalin peptides in the rat brain JCompNeurol 249 293 336
16. Fischli W. Goldstein A. Hunkapiller MW. Hood LE. 1982 Isolation and amino acid sequence analysis of a 4000-dalton dynorphin from porcine pituitary ProcNatl AcadSciUSA 79 5435 5437
17. Garzon J. Jen MF. Sanchez-Blazquez P. Lee NM. 1982 Dynorphin (1-13), a long-lasting inhibitor of opiate receptor binding in vitro Life Sci 31 1789 1792
18. Garzon J. Sanchez-Blazquez P. Gerhart J. Loh HH. Lee NM. 1984 Dynorphin1-13: interaction with other opiate ligand bindings in vitro Brain Res 302 392 396
19. 35S]GTPγS binding assay: approaches and applications in pharmacology Life Sci 74 489 508
20. Herrera-Marschitz M. Christensson-Nylander I. Sharp T. Staines W. Reid M. Hokfelt T. Terenius L. Ungerstedt U. 1986 Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis ExpBrain Res 64 193 207
21. Hewlett WA. Barchas JD. 1983 Regional interactions of opioid peptides at μ and † sites in rat brain Peptides 4 853 858
22. Holst B. Hastrup H. Raffetseder U. Martini L. Schwartz TW. 2001 Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis JBiolChem 276 19793 19799
23. Huidobro-Toro JP. Yoshimura K. Lee NM. Loh HH. Way EL. 1981 Dynorphin interaction at the κ-opiate site EurJPharmacol 72 265 266
24. Hurd YL. 2002 Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex MolPsychiat 7 75 81
25. Hurd YL. Herkenham M. 1993 Molecular alterations in the neostriatum of human cocaine addicts Synapse 13 357 369
26. Hurd YL. Herman MM. Hyde TM. Bigelow LB. Weinberger DR. Kleinman JE. 1997 Prodynorphin mRNA expression is increased in the patch versus matrix compartment of the caudate nucleus in suicide subjects MolPsychiat 2 495 500
27. James IF. Chavkin C. Goldstein A. 1982 Selectivity of dynorphin for κopioid receptors Life Sci 31 1331 1334
28. James IF. Fischli W. Goldstein A. 1984 Opioid receptor selectivity of dynorphin gene products JPharmacolExpTher 228 88 93
29. Ji RR. Befort K. Brenner GJ. Woolf CJ. 2002 ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and nk-1 upregulation and contributes to persistent inflammatory pain hypersensitivity JNeurosci 22 478 485
30. Josefsen K. Buschard K. Sorensen LR. Wollike M. Ekman R. Birkenbach M. 1998 Glucose stimulation of pancreatic β-cell lines induces expression and secretion of dynorphin Endocrinology 139 4329 4336
31. Kangawa K. Minamino N. Chino N. Sakakibara S. Matsuo H. 1981 The complete amino acid sequence of α-neo-endorphin BiochemBiophysResCommun 99 871 878
32. Kawasaki AM. Knapp RJ. Walton A. Wire WS. Zalewska T. Yamamura HI. Porreca F. Burks TF. Hruby VJ. 1993 q14 Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions, 1, 6, 7, 8 and 10 IntJPeptProtein Res 42 411 449
33. Kenakin T. 1997 Agonist-specific receptor conformations Trends PharmacolSci 18 416 417
34. Khachaturian H. Schafer MK-H. Lewis ME. 1993 q15 Anatomy and function of the endogenous opioid system, in Handbook of Experimental Pharmacologyq16 Herz A., ed.), pp. 471 497 Springer-Verlag Berlin, New York
35. Kreek MJ. LaForge KS. Butelman E. 2002 Pharmacotherapy of addictions NatRevDrug Discov 1 710 726
36. Kuzmin A. Madjid N. Terenius L. Ogren SO. Bakalkin G. 2005 Memory-enhancing, anxiolytic-like and locomotor effects of big dynorphin, a prodynorphin derived peptide, are mediated through NMDA receptors Neuropsychopharmacology (published online ahead of print).
37. Leslie FM. Chavkin C. Cox BM. 1980 Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites JPharmacolExpTher 214 395 402
38. Lu Y. Nguyen TM. Weltrowska G. Berezowska I. Lemieux C. Chung NN. Schiller PW. 2001 [2′,6′-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective κopioid antagonists JMedChem 44 3048 3053
39. Mansour A. Fox CA. Meng F. Watson SJ. Akil H. 1994 κ1 Receptor mRNA distribution in the rat CNS: comparison to κreceptor binding and prodynorphin mRNA MolCellNeurosci 5 124 144
40. Marinova Z. Vukojevic V. Surcheva S. et al. 2005 Translocation of dynorphin neuropeptides across the plasma membrane: a putative mechanism of signal transmission JBiolChem 280 26 360 26 370
41. McGinty JF. Henriksen SJ. Goldstein A. Terenius L. Bloom FE. 1983 Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity ProcNatl AcadSciUSA 80 589 593
42. McLaughlin JP. Marton-Popovici M. Chavkin C. 2003 κOpioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses JNeurosci 13 5674 5683
43. Meng F. Hoversten MT. Thompson RC. Taylor L. Watson SJ. Akil H. 1995 A chimeric study of the molecular basis of affinity and selectivity of the κand the † opioid receptors. Potential role of extracellular domains JBiolChem 270 12730 12736
44. Naito A. Nishimura K. 2004 Conformational analysis of opioid peptides in the solid states and the membrane environments by NMR spectroscopy CurrTopMedChem 4 135 145
45. Naranjo JR. Mellstrom B. Achaval M. Sassone-Corsi P. 1991 Molecular pathways of pain: Fos/Jun-mediated activation of a non-canonical AP-1 site in the prodynorphin gene Neuron 6 607 617
46. Nestler EJ. 2001 Molecular basis of long-term plasticity underlying addiction NatRevNeurosci 2 119 128 ; erratum Nat. Rev. Neurosci. (2001) 2, 215.
47. Ozawa S. Kamiya H. Tsuzuki K. 1998 Glutamate receptors in the mammalian central nervous system ProgNeurobiol 54 581 618
48. Palanche T. Ilien B. Zoffmann S. Reck MP. Bucher B. Edelstein SJ. Galzi JL. 2001 The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states JBiolChem 276 34853 34861
49. Paterlini G. Portoghese PS. Ferguson DM. 1997 Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the κ-opioid receptor. A model for receptor activation JMedChem 40 3254 3262
50. Pierce JP. Kurucz OS. Milner TA. 1999 Morphometry of a peptidergic transmitter system: dynorphin B-like immunoreactivity in the rat hippocampal mossy fiber pathway before and after seizures Hippocampus 9 255 276
51. Quirion R. Pert CB. 1981 Dynorphins: similar relative potencies on μ-, †- and κ-opiate receptors EurJPharmacol 76 467 468
52. Rashid AJ. O'Dowd BF. George SR. 2004 Minireview: diversity and complexity of signaling through peptidergic G protein-coupled receptors Endocrinology 145 2645 2652
53. Rezvani A. Hollt V. Way EL. 1983 K receptor activities of the three opioid peptide families Life Sci 33 271 274
54. Sargent DF. Schwyzer R. 1986 Membrane lipid phase as catalyst for peptide-receptor interactions ProcNatl AcadSciUSA 83 5774 5778
55. Seizinger BR. Grimm C. Hollt V. Herz A. 1984 Evidence for a selective processing of pro-enkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary JNeurochem 42 447 457
56. Sharifi N. Diehl N. Yaswen L. Brennan MB. Hochgeschwender U. 2001 Generation of dynorphin knockout mice Brain ResMolBrain Res 86 70 75
57. Sheffler DJ. Roth BL. 2003 Salvinorin A: the 'magic mint' hallucinogen finds a molecular target in the κopioid receptor Trends PharmacolSci 24 107 109
58. Shuster SJ. Riedl M. Li X. Vulchanova L. Elde R. 2000 The κopioid receptor and dynorphin co-localize in vasopressin magnocellular neurosecretory neurons in guinea-pig hypothalamus Neuroscience 96 373 383
59. Solbrig MV. Koob GF. 2004 Epilepsy, CNS viral injury and dynorphin Trends PharmacolSci 25 98 104
60. Svingos AL. Colago EE. Pickel VM. 1999 Cellular sites for dynorphin activation of κ-opioid receptors in the rat nucleus accumbens shell JNeurosci 19 1804 1813
61. Tan-No K. Esashi A. Nakagawasai O. Niijima F. Tadano T. Sakurada C. Sakurada T. Bakalkin G. Terenius L. Kisara K. 2002 Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl- d -aspartate receptor mechanism Brain Res 952 7 14
62. Tan-No K. Takahashi H. Nakagawasai O. et al. 2005 Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation Pain 113 301 309
63. Tota MR. Schimerlik MI. 1990 Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system MolPharmacol 37 996 1004
64. Traynor JR. Clark MJ. Remmers AE. 2002 Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists JPharmacolExpTher 300 157 161
65. Vig BS. Murray TF. Aldrich JV. 2003 A novel N-terminal cyclic dynorphin A analogue cyclo(N,5)[Trp(3),Trp(4),Glu(5)] dynorphin A-(1-11)NH(2) that lacks the basic N-terminus JMedChem 46 1279 1282
66. de Vries TJ. Shippenberg TS. 2002 Neural systems underlying opiate addiction JNeurosci 22 3321 3325
67. Wang Z. Gardell L. Ossipov MH. et al. 2001 Pronociceptive actions of dynorphin maintain chronic neuropathic pain JNeurosci 21 1779 1786
68. Wuster M. Rubini P. Schulz R. 1981 The preference of putative pro-enkephalins for different types of opiate receptors Life Sci 29 1219 1227
69. Xie GX. Goldstein A. 1987 Characterization of big dynorphins from rat brain and spinal cord JNeurosci 7 2049 2055
70. Xu M. Petraschka M. McLaughlin JP. Westenbroek RE. Caron MG. Lefkowitz RJ. Czyzyk TA. Pintar JE. Terman GW. Chavkin C. 2004 Neuropathic pain activates the endogenous κopioid system in mouse spinal cord and induces opioid receptor tolerance JNeurosci 24 4576 4584
71. 3H]Dynorphin binding to guinea pig and rat brain Life Sci 33 287 290
72. 3H]Dynorphin A binding and κselectivity of prodynorphin peptides in rat, guinea-pig and monkey brain EurJPharmacol 121 355 365
73. Zhang S. Tong Y. Tian M. Dehaven RN. Cortesburgos L. Mansson E. Simonin F. Kieffer B. Yu L. 1998 Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family JPharmacolExpTher 286 136 141